Recent Comments

Comment RSS

Mesothelioma News and Research RSS Feed - Mesothelioma News and Research

Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.

EIN News launches "Mesothelioma News Today"

19. November 2009 07:27
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com). [More]

USPTO issues patent for Rosetta Genomics' human microRNA miR-193b

6. November 2009 03:36
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO. [More]

Posted in: Medical Science News | Medical Patent News

Tags: , , , , , , , ,

Study on asbestos-related diseases in Libby launched

4. November 2009 05:00
Over nearly a century, thousands of residents and workers in Libby, MT, have been exposed to asbestos-contaminated vermiculite ore, leading to markedly higher rates of lung disease and autoimmune disorders, and causing to Libby in 2002 to be added to the federal Environmental Protection Agency's "National Priorities List." [More]

Posted in: Medical Condition News

Tags: , , , , , , , , ,

Inhaling carbon nanotubes can affect outer lining of the lungs

26. October 2009 00:32
Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , ,

Rosetta Genomics, GTG sign exclusive distribution agreement

22. October 2009 08:20
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics’ three currently available diagnostic tests. [More]

New health initiative focuses on environmentally-associated cancers

22. October 2009 02:57
The Barbara Ann Karmanos Cancer Institute, in cooperation with Blue Cross Blue Shield of Michigan (BCBSM), will launch a targeted health initiative in January 2010 focused on environmentally-associated cancers. [More]

Posted in: Medical Condition News | Healthcare News

Tags: , , , , , , ,

Prometheus Laboratories introduces three new cancer diagnostic products

15. October 2009 07:52
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx. Each of these tests is based on recently developed, highly sensitive microRNA technology. [More]

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

15. October 2009 00:40
Relying on an independent study by the Institute of Medicine (IOM), Secretary of Veterans Affairs Eric K. Shinseki decided to establish a service-connection for Vietnam Veterans with three specific illnesses based on the latest evidence of an association with the herbicides referred to as Agent Orange. [More]

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

21. September 2009 08:10
Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA(R) (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care. [More]

New interferon/lovastatin treatment to battle cancer

21. September 2009 01:46
For selected patients, he decided he might have something better. He now has opened NeoPlas Innovation in Nashville to offer the combination "off-label" treatment on an outpatient basis. [More]

Rosetta Genomics and AXA Diagnostics sign exclusive distribution agreement

8. September 2009 08:26
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution agreement in Italy for Rosetta Genomics’ three currently available diagnostic tests. [More]

New technique may help clinicians in diagnosing pleural effusion

24. August 2009 03:10
A new technique may help clinicians hone in on a diagnosis in patients presenting with a pleural effusion of unknown cause. [More]

FDA approves Alimta (pemetrexed) for advanced lung cancer

6. July 2009 19:35
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer. [More]

EPA declares first-ever public health emergency in Montana

18. June 2009 23:20
The Environmental Protection Agency yesterday declared its first-ever "public health emergency," asbestos contamination near Libby and Troy, Mont., northwestern mining towns, the Associated Press reports. [More]

Posted in: Miscellaneous News

Tags: ,

Discovery of mechanism of cell type-specific signaling in tumor development

8. April 2009 13:13
Mayo Clinic researchers have discovered the mechanisms behind two key checkpoints in cell growth and development - factors that may ultimately allow investigators to benchmark progression of tumor cells or stop them from further development. [More]

Posted in: Medical Research News

Tags: , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.